Based on previous large-scale in silico screening several factor Xa inhibitors were proposed to potentially inhibit SARS-CoV-2 Mpro. In addition to their known anticoagulants activity this potential inhibition could have an additional therapeutic effect on patients with COVID-19 disease. In this study we examined the binding of the Apixaban. Betrixaban and Rivaroxaban to the SARS-CoV-... https://www.chiggate.com/climax-blueberry-supply/